Edition:
United Kingdom

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

0.75USD
22 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.75
Open
$0.85
Day's High
$0.85
Day's Low
$0.75
Volume
252,761
Avg. Vol
177,895
52-wk High
$6.73
52-wk Low
$0.69

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.07 December 23 Apr 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 1 1 1
(2) OUTPERFORM 0 3 3 3
(3) HOLD 3 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 3 9.49 12.50 7.47 --
Quarter Ending Sep-19 3 6.58 8.50 3.74 --
Year Ending Dec-19 3 32.85 40.00 24.56 57.20
Year Ending Dec-20 2 17.50 35.00 0.00 38.21
Earnings (per share)
Quarter Ending Jun-19 3 -0.07 0.00 -0.16 --
Quarter Ending Sep-19 3 -0.11 -0.07 -0.16 --
Year Ending Dec-19 3 -0.36 -0.21 -0.60 0.13
Year Ending Dec-20 3 -0.52 -0.27 -0.82 -0.07

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 8.63 7.41 1.22 14.14
Quarter Ending Sep-18 9.78 7.67 2.11 21.62
Quarter Ending Jun-18 9.09 8.77 0.32 3.50
Quarter Ending Mar-18 8.88 9.74 0.86 9.70
Quarter Ending Dec-17 9.66 8.80 0.86 8.86
Earnings (per share)
Quarter Ending Dec-18 -0.14 -0.13 0.01 -9.72
Quarter Ending Sep-18 -0.15 -0.15 0.00 -2.60
Quarter Ending Jun-18 -0.20 -0.15 0.05 -25.00
Quarter Ending Mar-18 -0.17 -0.17 0.00 -1.90
Quarter Ending Dec-17 -0.17 -0.15 0.02 -10.87

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-19 9.49 9.49 10.50 11.75 --
Quarter Ending Sep-19 6.58 6.58 8.00 8.00 --
Year Ending Dec-19 32.85 32.85 40.87 41.87 57.20
Year Ending Dec-20 17.50 17.50 36.63 44.13 38.21
Earnings (per share)
Quarter Ending Jun-19 -0.07 -0.07 -0.09 -0.03 --
Quarter Ending Sep-19 -0.11 -0.11 -0.11 -0.12 --
Year Ending Dec-19 -0.36 -0.36 -0.15 -0.16 0.13
Year Ending Dec-20 -0.52 -0.52 -0.40 -0.27 -0.07

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-19 0 0 0 0
Quarter Ending Sep-19 0 0 0 0
Year Ending Dec-19 0 0 0 1
Year Ending Dec-20 0 0 0 0
Earnings
Quarter Ending Jun-19 0 0 0 0
Quarter Ending Sep-19 0 0 0 0
Year Ending Dec-19 0 0 0 0
Year Ending Dec-20 0 0 0 0